Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKYA NYSE:INTT NASDAQ:QSI NASDAQ:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKYAAkoya Biosciences$1.29$1.28$0.93▼$1.64$64.44M1.36657,305 shsN/AINTTinTEST$18.44-2.4%$15.54$5.64▼$20.00$231.70M1.55198,012 shs583,908 shsQSIQuantum-Si$0.89-4.6%$0.89$0.69▼$3.10$193.83M3.156.50 million shs3.68 million shsSENSSenseonics Holdings, Inc. Common Stock$5.77-0.9%$6.37$4.79▼$12.58$241.20M1.051.28 million shs364,205 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKYAAkoya Biosciences0.00%0.00%0.00%0.00%+36.41%INTTinTEST0.00%+6.90%+9.76%+75.62%+204.79%QSIQuantum-Si0.00%-1.82%-14.41%-10.15%-41.44%SENSSenseonics Holdings, Inc. Common Stock0.00%+14.71%-14.77%+576,999,900.00%+576,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKYAAkoya Biosciences$1.29$1.28$0.93▼$1.64$64.44M1.36657,305 shsN/AINTTinTEST$18.44-2.4%$15.54$5.64▼$20.00$231.70M1.55198,012 shs583,908 shsQSIQuantum-Si$0.89-4.6%$0.89$0.69▼$3.10$193.83M3.156.50 million shs3.68 million shsSENSSenseonics Holdings, Inc. Common Stock$5.77-0.9%$6.37$4.79▼$12.58$241.20M1.051.28 million shs364,205 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKYAAkoya Biosciences0.00%0.00%0.00%0.00%+36.41%INTTinTEST0.00%+6.90%+9.76%+75.62%+204.79%QSIQuantum-Si0.00%-1.82%-14.41%-10.15%-41.44%SENSSenseonics Holdings, Inc. Common Stock0.00%+14.71%-14.77%+576,999,900.00%+576,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKYAAkoya Biosciences 2.00Hold$1.08-16.28% DownsideINTTinTEST 3.50Strong Buy$19.003.04% UpsideQSIQuantum-Si 2.00Hold$3.25265.13% UpsideSENSSenseonics Holdings, Inc. Common Stock 2.67Moderate Buy$17.00194.63% UpsideCurrent Analyst Ratings BreakdownLatest AKYA, SENS, INTT, and QSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2026SENSSenseonics Holdings, Inc. Common Stock HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$18.50 ➝ $14.005/11/2026SENSSenseonics Holdings, Inc. Common Stock Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.005/5/2026INTTinTEST Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy3/27/2026QSIQuantum-Si Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/4/2026QSIQuantum-Si Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$1.50 ➝ $1.003/3/2026SENSSenseonics Holdings, Inc. Common Stock Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$9.003/2/2026INTTinTEST Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$10.00 ➝ $19.002/17/2026SENSSenseonics Holdings, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageSell (D-)(Data available from 5/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKYAAkoya Biosciences$79.96M0.81N/AN/A$0.15 per share8.60INTTinTEST$121.07M1.91$3.21 per share5.75$7.92 per share2.33QSIQuantum-Si$2.44M79.44N/AN/A$0.92 per share0.97SENSSenseonics Holdings, Inc. Common Stock$35.26M6.84N/AN/A$0.82 per share7.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKYAAkoya Biosciences-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%N/AINTTinTEST$9.34M$0.0480.1846.10N/A2.33%5.31%3.42%N/AQSIQuantum-Si-$101.34M-$0.51N/AN/AN/A-5,605.88%-47.35%-42.66%8/4/2026 (Estimated)SENSSenseonics Holdings, Inc. Common Stock-$69.11M-$2.00N/AN/AN/A-213.87%-129.97%-67.14%N/ALatest AKYA, SENS, INTT, and QSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026QSIQuantum-Si-$0.12-$0.10+$0.02-$0.10$0.30 million$0.26 million5/7/2026Q1 2026SENSSenseonics Holdings, Inc. Common Stock-$0.65-$0.71-$0.06-$0.71N/A$11.71 million3/3/2026Q4 2025QSIQuantum-Si-$0.14-$0.08+$0.06-$0.08$0.76 million$0.45 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAKYAAkoya BiosciencesN/AN/AN/AN/AN/AINTTinTESTN/AN/AN/AN/AN/AQSIQuantum-SiN/AN/AN/AN/AN/ASENSSenseonics Holdings, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKYAAkoya Biosciences10.120.610.40INTTinTEST0.082.261.38QSIQuantum-SiN/A12.607.50SENSSenseonics Holdings, Inc. Common Stock1.053.514.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKYAAkoya Biosciences79.42%INTTinTEST63.18%QSIQuantum-Si39.90%SENSSenseonics Holdings, Inc. Common Stock12.36%Insider OwnershipCompanyInsider OwnershipAKYAAkoya Biosciences7.30%INTTinTEST5.20%QSIQuantum-Si22.04%SENSSenseonics Holdings, Inc. Common Stock4.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKYAAkoya Biosciences9049.95 million46.31 millionOptionableINTTinTEST32012.57 million11.69 millionOptionableQSIQuantum-Si150217.76 million169.77 millionOptionableSENSSenseonics Holdings, Inc. Common Stock9041.80 million39.84 millionN/AAKYA, SENS, INTT, and QSI HeadlinesRecent News About These CompaniesSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 22,686 SharesMay 14 at 8:19 AM | insidertrades.comHC Wainwright Has Optimistic Outlook of SENS Q2 EarningsMay 14 at 7:28 AM | marketbeat.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Price Target Lowered to $14.00 at HC WainwrightMay 13, 2026 | americanbankingnews.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Price Target Cut to $8.00 by Analysts at Stifel NicolausMay 12, 2026 | americanbankingnews.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Price Target Lowered to $8.00 at Stifel NicolausMay 11, 2026 | marketbeat.comSenseonics Holdings, Inc. (NASDAQ:SENS) Q1 2026 Earnings Call TranscriptMay 10, 2026 | insidermonkey.comSenseonics Holdings, Inc. Common Stock Q1 Earnings Call HighlightsMay 8, 2026 | marketbeat.comSenseonics Holdings, Inc. (SENS) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comSenseonics Holdings (SENS) Reports Q1 Loss, Beats Revenue EstimatesMay 7, 2026 | zacks.comSenseonics Holdings, Inc. Reports First Quarter 2026 Financial ResultsMay 7, 2026 | globenewswire.comSenseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesMay 5, 2026 | markets.businessinsider.comSenseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesMay 4, 2026 | globenewswire.comSenseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 MillionMay 4, 2026 | globenewswire.comSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Average Recommendation of "Moderate Buy" by BrokeragesMay 4, 2026 | marketbeat.comSenseonics shares sink Friday: What's driving the move?May 1, 2026 | msn.comSenseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern TimeMay 1, 2026 | globenewswire.comSenseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsApril 30, 2026 | globenewswire.comSenseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded WarrantsApril 30, 2026 | globenewswire.comSENS Launches Eversense 365, World's Only One-Year CGM in EuropeApril 27, 2026 | zacks.comSenseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM SystemApril 24, 2026 | globenewswire.comSymmetry Partners LLC Reduces Stock Holdings in Senseonics Holdings, Inc. Common Stock $SENSApril 20, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSanDisk Earnings Crush Estimates With 251% Revenue SurgeBy Ryan Hasson | May 1, 2026Intuitive Surgical's Selloff Sets Up a 30% Rebound OpportunityBy Thomas Hughes | April 23, 2026The USMCA Review Is Coming: 3 Border-Sensitive Stocks to WatchBy Chris Markoch | May 8, 2026Niccol Effect Has Starbucks Stock Barreling Toward Fresh HighsBy Thomas Hughes | April 29, 2026The New Fed Chair Trade: Who Wins When Warsh Takes the Helm?By Chris Markoch | May 5, 2026AKYA, SENS, INTT, and QSI Company DescriptionsAkoya Biosciences NASDAQ:AKYAAkoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.inTEST NYSE:INTT$18.44 -0.46 (-2.43%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$18.86 +0.42 (+2.27%) As of 05/15/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Quantum-Si NASDAQ:QSI$0.89 -0.04 (-4.59%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$0.90 +0.01 (+1.11%) As of 05/15/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.Senseonics Holdings, Inc. Common Stock NASDAQ:SENS$5.77 -0.05 (-0.86%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$5.74 -0.02 (-0.43%) As of 05/15/2026 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Peloton Stock Gives Back Gains After Upbeat Earnings Report MarketBeat Week in Review – 05/11 - 05/15 Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Alphabet's Googlebook Brings Gemini AI to PC Hardware Viking Sails to All-Time Highs—Fundamentals Signal More to Come YETI Rallies After Earnings Beat and Raised Outlook Aeluma's Post-Earnings Dip Creates a Buying Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
